Arch Point Investors Dbv Technologies S.A. Transaction History

Arch Point Investors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$18.6 - $24.94 $1.43 Million - $1.91 Million	-76,660 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$20.86 - $26.6 $20 - $26	1 Added 0.0%	76,660 $1.89 Million
Q4 2017 Feb 14, 2018	BUY	$20.9 - $49.36 $260,037 - $614,137	12,442 Added 19.37%	76,659 $1.89 Million
Q3 2017 Nov 14, 2017	BUY	$39.62 - $46.17 $2.54 Million - $2.96 Million	64,217	64,217 $2.73 Million

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $571M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Arch Point Investors, based on Form 13F filings with the SEC.

Stay updated on Arch Point Investors with notifications on news.